THE BIOAVAILABILITY, ABSORPTION CHARACTERISTICS AND FORMULATION OF 4 COMMERCIALLY-AVAILABLE CONTROLLED-RELEASE THEOPHYLLINE PRODUCTS

被引：5

作者：

SUMMERS, RS

SUMMERS, B

RAWNSLEY, S

机构：

来源：

INTERNATIONAL JOURNAL OF PHARMACEUTICS | 1986年 / 30卷 / 01期

关键词：

D O I：

10.1016/0378-5173(86)90138-9

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：83 / 88

页数：6

共 17 条

[1] ABSORPTION KINETICS AND STEADY-STATE PLASMA-CONCENTRATIONS OF THEOPHYLLINE FOLLOWING THERAPEUTIC DOSES OF 2 SUSTAINED-RELEASE PREPARATIONS [J].

ANDERSEN, O ;

NIELSEN, MK ;

ERIKSEN, PB ;

FENGER, M ;

KNUDSEN, PJ .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1983, 72 (02) :158-161

[2] THE COMPARATIVE BIOAVAILABILITY OF SLOW RELEASE ORAL THEOPHYLLINE PREPARATIONS [J].

EDWARDS, C ;

COPE, AS ;

JACKSON, AH ;

PURKISS, R .

JOURNAL OF CLINICAL AND HOSPITAL PHARMACY, 1983, 8 (01) :63-67

[3] CLINICAL EXPERIENCE WITH THEOPHYLLINE - RELATIONSHIPS BETWEEN DOSAGE, SERUM CONCENTRATION, AND TOXICITY [J].

JACOBS, MH ;

SENIOR, RM ;

KESSLER, G .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1976, 235 (18) :1983-1986

[4]

JENNE JW, 1972, CLIN PHARMACOL THER, V13, P349

[5] AN INVIVO SINGLE-DOSE AND MULTIPLE-DOSE STUDY OF SEVERAL MARKETED BRANDS OF CONVENTIONAL AND CONTROLLED-RELEASE THEOPHYLLINE [J].

KOTZAN, JA ;

VALLNER, JV ;

STEWART, JT ;

HONIGBERG, IL ;

BROWN, WJ .

DRUG INTELLIGENCE & CLINICAL PHARMACY, 1984, 18 (02) :147-153

[6] GREATLY ENHANCED BIOAVAILABILITY OF THEOPHYLLINE ON POSTPRANDIAL ADMINISTRATION OF A SUSTAINED-RELEASE TABLET [J].

LAGAS, M ;

JONKMAN, JHG .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 24 (06) :761-767

[7]

MANGUES MA, 1984, 13TH EUR S CLIN PHAR

[8] RATIONAL INTRAVENOUS DOSES OF THEOPHYLLINE [J].

MITENKO, PA ;

OGILVIE, RI .

NEW ENGLAND JOURNAL OF MEDICINE, 1973, 289 (12) :600-603

[9]

PAIFSKY KM, 1975, NEW ENGL J MED, V292, P1218

[10]

SKINNER M, 1983, SA PHARM J, V50, P557

← 1 2 →